Media Summary: Benjamin Derman, MD, The University of Chicago, Chicago, IL, discusses measurable residual disease ( Radhika Bansal, MBBS, Mayo Clinic, Rochester, MN, talks on the use of measurable residual disease ( Benjamin Derman, MD, University of Chicago, Chicago, IL, shares insights into the use of measurable residual disease (
Mrd Guided Therapy In Multiple Myeloma - Detailed Analysis & Overview
Benjamin Derman, MD, The University of Chicago, Chicago, IL, discusses measurable residual disease ( Radhika Bansal, MBBS, Mayo Clinic, Rochester, MN, talks on the use of measurable residual disease ( Benjamin Derman, MD, University of Chicago, Chicago, IL, shares insights into the use of measurable residual disease ( Meletios Dimopoulos, MD, Kapodistrian University of Athens School of Medicine, Athens, Greece, comments on the potential for ... Noemí Puig, MD, PhD, University Hospital Salamanca, Salamanca, Spain, comments on the evolving use of measurable residual ... Francesco Maura, MD, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, comments on the use of ...
Mattia D'Agostino, MD, University of Turin, European Ola Landgren, MD, PhD, of Sylvester Comprehensive Cancer Center, University of Miami, FL, discusses measurable residual ... Discover how measurable residual disease ( In this video, Bruno Paiva, PhD, University of Navarra, Pamplona, Spain, shares some insights into the pros and cons of using ... Claudio Cerchione, MD, PhD, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy, talks ... Ola Landgren, MD, PhD, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, discusses the importance of ...
Benjamin Derman, MD, from the University of Chicago, Chicago, IL, talks about how Larry Anderson, MD, PhD, UT Southwestern Medical Center, Dallas, TX, comments on the role of measurable residual disease ... Jesús San Miguel, MD, PhD, University of Navarra, Pamplona, Spain, comments on the role of measurable residual disease ... In this video, Noemí Puig, MD, PhD, University Hospital Salamanca, Salamanca, Spain, outlines findings of the GEM2014MAIN ... Nikhil C. Munshi, MD, and Parameswaran Hari, MD, MRCP, debate the role of minimal residual disease ( Paul Richardson, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the updated results of the MIDAS study ...
